Cargando…
Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers
Early diagnosis and dietary treatment do not prevent long-term complications, which mostly affect the central nervous system in classical galactosemia patients. The clinical outcome of patients is highly variable, and there is an urgent need for prognostic biomarkers. The aim of this study was first...
Autores principales: | Welsink-Karssies, Mendy M, Ferdinandusse, Sacha, Geurtsen, Gert J, Hollak, Carla E M, Huidekoper, Hidde H, Janssen, Mirian C H, Langendonk, Janneke G, van der Lee, Johanna H, O’Flaherty, Roisin, Oostrom, Kim J, Roosendaal, Stefan D, Rubio-Gozalbo, M Estela, Saldova, Radka, Treacy, Eileen P, Vaz, Fred M, de Vries, Maaike C, Engelen, Marc, Bosch, Annet M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425409/ https://www.ncbi.nlm.nih.gov/pubmed/32954279 http://dx.doi.org/10.1093/braincomms/fcaa006 |
Ejemplares similares
-
Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
por: Welsink-Karssies, Mendy M., et al.
Publicado: (2020) -
Correction to: Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
por: Welsink-Karssies, Mendy M., et al.
Publicado: (2020) -
Cognitive functioning in patients with classical galactosemia: a systematic review
por: Hermans, Merel E., et al.
Publicado: (2019) -
The 1‐(13)C galactose breath test in GALT deficient patients distinguishes NBS detected variant patients but does not predict outcome in classical phenotypes
por: Welsink‐Karssies, Mendy M., et al.
Publicado: (2020) -
Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021)